China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.95% | -45.51% | 0.19% | 41.72% | 63.26% |
| Total Depreciation and Amortization | 256.12% | 197.78% | 13.02% | -48.92% | -56.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -96.17% | -100.66% | -135,010.89% | 114.54% | -27.93% |
| Change in Net Operating Assets | 1.55% | -36.25% | 1,307.71% | -115.72% | -18.74% |
| Cash from Operations | -111.96% | 24.97% | -49.13% | -404.26% | 477.30% |
| Capital Expenditure | -- | -- | 97.44% | -106.52% | 100.36% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 97.91% | -- | -- |
| Cash from Investing | -- | -- | 97.87% | -541.30% | 100.36% |
| Total Debt Issued | -83.55% | -- | 10,305.88% | -10,985.29% | 96.19% |
| Total Debt Repaid | 95.74% | -3.26% | -1,176.92% | -- | -106.19% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 636.16% | -3.26% | -33.70% | -1,897.06% | -424.64% |
| Foreign Exchange rate Adjustments | 223.99% | -677.78% | 106.15% | 315.69% | -607.14% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -35.75% | 17.55% | 184.42% | -1,634.95% | 313.37% |